DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Treatment With Nab-paclitaxel in Cutaneous SCC

Phase 2

Terminated

Conditions: Cutaneous Squamous Cell Carcinoma

Interventions: Drug: nab-paclitaxel

First Posted Date: 2014-03-03

Last Posted Date: 2017-10-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 2

Registration Number: NCT02076243

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

Not Applicable

Completed

Conditions: Oropharyngeal Squamous Cell Carcinoma
Human Papilloma Virus

Interventions: Procedure: PET/CT
Radiation: Concurrent Chemoradiation
Radiation: Radiotherapy

First Posted Date: 2014-02-26

Last Posted Date: 2024-05-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 112

Registration Number: NCT02072148

Locations: 🇺🇸
Mount Sinai Beth Israel, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

Completed

Conditions: Crohn's Disease
Ulcerative Colitis

First Posted Date: 2014-02-04

Last Posted Date: 2017-09-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 974

Registration Number: NCT02054533

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 21 locations

Monitoring With Ultrasound Imaging of Intrauterine Device (IUD) Position Placed Immediately After Giving Birth

Completed

Conditions: Postpartum
Contraception

Interventions: Other: Immediate postpartum placement of IUD

First Posted Date: 2013-12-31

Last Posted Date: 2017-10-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 96

Registration Number: NCT02024672

Locations: 🇺🇸
Elmhurst Hospital Center, Elmhurst, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Healthy Body Study

Not Applicable

Terminated

Conditions: Obesity

Interventions: Behavioral: Healthy Weight
Behavioral: Controlled Intervention

First Posted Date: 2013-12-13

Last Posted Date: 2016-02-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 80

Registration Number: NCT02011646

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Does a Transabdominal Plane Block Decrease Patient Pain After Ventral Hernia Repair?

Phase 2

Completed

Conditions: Incisional Hernia
Pain, Postoperative
Ventral Hernia
Umbilical Hernia
Postoperative Complications

Interventions: Drug: Transabdominal Plane Block
Drug: Non Transabdominal Plane Block

First Posted Date: 2013-12-10

Last Posted Date: 2018-01-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 127

Registration Number: NCT02007096

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Early Protein Supplementation of Human Milk in Extremely Low Birth Weight Infants

Phase 2

Completed

Conditions: Growth in Premature Infants

Interventions: Dietary Supplement: liquid protein supplement

First Posted Date: 2013-11-25

Last Posted Date: 2015-09-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 43

Registration Number: NCT01991613

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism

Phase 4

Completed

Conditions: Mild Hypercortisolism

Interventions: Drug: Mifepristone

First Posted Date: 2013-11-21

Last Posted Date: 2018-03-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 8

Registration Number: NCT01990560

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat

Not Applicable

Completed

Conditions: Generalized Anxiety Disorder
Major Depressive Disorder

Interventions: Drug: seroquel xr
Behavioral: CBT

First Posted Date: 2013-10-29

Last Posted Date: 2018-02-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 62

Registration Number: NCT01971203

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder

Phase 2

Terminated

Conditions: Autism Spectrum Disorder

Interventions: Drug: Placebo/saline
Drug: IGF-1

First Posted Date: 2013-10-28

Last Posted Date: 2024-02-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 3

Registration Number: NCT01970345

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy